Reducing treatment side effects of aortic valve disease
Transcatheter aortic valve implantation (TAVI) is a popular treatment for aortic valve disease, especially for the elderly. However, there is a high risk of stroke after TAVI procedure in 5–7 % of the patients, due to cerebral embolic signals. To address this problem, the EU-funded OPTAVI project aims to optimise the performance of cerebral embolic protection devices (CEPD), which are used to reduce the debris going to the brain. Scientists will obtain a more in-depth physical understanding to enhance the hydrodynamic efficacy of CEPD and generate a CEPD design that offers maximum cerebral protection.
Fields of science
Call for proposal
See other projects for this call